Copyright Reports & Markets. All rights reserved.

Global Lou Gehrigs Disease Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Lou Gehrigs Disease

      • 1.1 Definition of Lou Gehrigs Disease
      • 1.2 Lou Gehrigs Disease Segment by Type
        • 1.2.1 Global Lou Gehrigs Disease Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Riluzole
        • 1.2.3 Edaravone (Radicava)
      • 1.3 Lou Gehrigs Disease Segment by Applications
        • 1.3.1 Global Lou Gehrigs Disease Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail & Online Pharmacie
      • 1.4 Global Lou Gehrigs Disease Overall Market
        • 1.4.1 Global Lou Gehrigs Disease Revenue (2014-2025)
        • 1.4.2 Global Lou Gehrigs Disease Production (2014-2025)
        • 1.4.3 North America Lou Gehrigs Disease Status and Prospect (2014-2025)
        • 1.4.4 Europe Lou Gehrigs Disease Status and Prospect (2014-2025)
        • 1.4.5 China Lou Gehrigs Disease Status and Prospect (2014-2025)
        • 1.4.6 Japan Lou Gehrigs Disease Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Lou Gehrigs Disease Status and Prospect (2014-2025)
        • 1.4.8 India Lou Gehrigs Disease Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Lou Gehrigs Disease
      • 2.3 Manufacturing Process Analysis of Lou Gehrigs Disease
      • 2.4 Industry Chain Structure of Lou Gehrigs Disease

      3 Development and Manufacturing Plants Analysis of Lou Gehrigs Disease

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Lou Gehrigs Disease Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Lou Gehrigs Disease
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Lou Gehrigs Disease Production and Capacity Analysis
      • 4.2 Lou Gehrigs Disease Revenue Analysis
      • 4.3 Lou Gehrigs Disease Price Analysis
      • 4.4 Market Concentration Degree

      5 Lou Gehrigs Disease Regional Market Analysis

      • 5.1 Lou Gehrigs Disease Production by Regions
        • 5.1.1 Global Lou Gehrigs Disease Production by Regions
        • 5.1.2 Global Lou Gehrigs Disease Revenue by Regions
      • 5.2 Lou Gehrigs Disease Consumption by Regions
      • 5.3 North America Lou Gehrigs Disease Market Analysis
        • 5.3.1 North America Lou Gehrigs Disease Production
        • 5.3.2 North America Lou Gehrigs Disease Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Lou Gehrigs Disease Import and Export
      • 5.4 Europe Lou Gehrigs Disease Market Analysis
        • 5.4.1 Europe Lou Gehrigs Disease Production
        • 5.4.2 Europe Lou Gehrigs Disease Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Lou Gehrigs Disease Import and Export
      • 5.5 China Lou Gehrigs Disease Market Analysis
        • 5.5.1 China Lou Gehrigs Disease Production
        • 5.5.2 China Lou Gehrigs Disease Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Lou Gehrigs Disease Import and Export
      • 5.6 Japan Lou Gehrigs Disease Market Analysis
        • 5.6.1 Japan Lou Gehrigs Disease Production
        • 5.6.2 Japan Lou Gehrigs Disease Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Lou Gehrigs Disease Import and Export
      • 5.7 Southeast Asia Lou Gehrigs Disease Market Analysis
        • 5.7.1 Southeast Asia Lou Gehrigs Disease Production
        • 5.7.2 Southeast Asia Lou Gehrigs Disease Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Lou Gehrigs Disease Import and Export
      • 5.8 India Lou Gehrigs Disease Market Analysis
        • 5.8.1 India Lou Gehrigs Disease Production
        • 5.8.2 India Lou Gehrigs Disease Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Lou Gehrigs Disease Import and Export

      6 Lou Gehrigs Disease Segment Market Analysis (by Type)

      • 6.1 Global Lou Gehrigs Disease Production by Type
      • 6.2 Global Lou Gehrigs Disease Revenue by Type
      • 6.3 Lou Gehrigs Disease Price by Type

      7 Lou Gehrigs Disease Segment Market Analysis (by Application)

      • 7.1 Global Lou Gehrigs Disease Consumption by Application
      • 7.2 Global Lou Gehrigs Disease Consumption Market Share by Application (2014-2019)

      8 Lou Gehrigs Disease Major Manufacturers Analysis

      • 8.1 AB Science
        • 8.1.1 AB Science Lou Gehrigs Disease Production Sites and Area Served
        • 8.1.2 AB Science Product Introduction, Application and Specification
        • 8.1.3 AB Science Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Avicena Group
        • 8.2.1 Avicena Group Lou Gehrigs Disease Production Sites and Area Served
        • 8.2.2 Avicena Group Product Introduction, Application and Specification
        • 8.2.3 Avicena Group Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Biogen
        • 8.3.1 Biogen Lou Gehrigs Disease Production Sites and Area Served
        • 8.3.2 Biogen Product Introduction, Application and Specification
        • 8.3.3 Biogen Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 BrainStorm Therapeutics
        • 8.4.1 BrainStorm Therapeutics Lou Gehrigs Disease Production Sites and Area Served
        • 8.4.2 BrainStorm Therapeutics Product Introduction, Application and Specification
        • 8.4.3 BrainStorm Therapeutics Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Covis Pharmaceutical Inc.
        • 8.5.1 Covis Pharmaceutical Inc. Lou Gehrigs Disease Production Sites and Area Served
        • 8.5.2 Covis Pharmaceutical Inc. Product Introduction, Application and Specification
        • 8.5.3 Covis Pharmaceutical Inc. Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Cytokinetics Inc.
        • 8.6.1 Cytokinetics Inc. Lou Gehrigs Disease Production Sites and Area Served
        • 8.6.2 Cytokinetics Inc. Product Introduction, Application and Specification
        • 8.6.3 Cytokinetics Inc. Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Eisai Co. Ltd.
        • 8.7.1 Eisai Co. Ltd. Lou Gehrigs Disease Production Sites and Area Served
        • 8.7.2 Eisai Co. Ltd. Product Introduction, Application and Specification
        • 8.7.3 Eisai Co. Ltd. Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 GlaxoSmithKline plc.
        • 8.8.1 GlaxoSmithKline plc. Lou Gehrigs Disease Production Sites and Area Served
        • 8.8.2 GlaxoSmithKline plc. Product Introduction, Application and Specification
        • 8.8.3 GlaxoSmithKline plc. Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Ionis Pharmaceuticals, Inc.
        • 8.9.1 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Production Sites and Area Served
        • 8.9.2 Ionis Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.9.3 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Mitsubishi Tanabe Pharma Corp.
        • 8.10.1 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Production Sites and Area Served
        • 8.10.2 Mitsubishi Tanabe Pharma Corp. Product Introduction, Application and Specification
        • 8.10.3 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Neuralstem Inc.
      • 8.12 Neuraltus Pharmaceuticals Inc.
      • 8.13 Newron Pharmaceuticals S.p.A.
      • 8.14 Nutra Pharma Corp.
      • 8.15 Pharnext SAS
      • 8.16 Q-Therapeutics Inc.

      9 Development Trend of Analysis of Lou Gehrigs Disease Market

      • 9.1 Global Lou Gehrigs Disease Market Trend Analysis
        • 9.1.1 Global Lou Gehrigs Disease Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Lou Gehrigs Disease Regional Market Trend
        • 9.2.1 North America Lou Gehrigs Disease Forecast 2019-2025
        • 9.2.2 Europe Lou Gehrigs Disease Forecast 2019-2025
        • 9.2.3 China Lou Gehrigs Disease Forecast 2019-2025
        • 9.2.4 Japan Lou Gehrigs Disease Forecast 2019-2025
        • 9.2.5 Southeast Asia Lou Gehrigs Disease Forecast 2019-2025
        • 9.2.6 India Lou Gehrigs Disease Forecast 2019-2025
      • 9.3 Lou Gehrigs Disease Market Trend (Product Type)
      • 9.4 Lou Gehrigs Disease Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Lou Gehrigs Disease Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions of which ALS is the most common.

        The global Lou Gehrigs Disease market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Lou Gehrigs Disease volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lou Gehrigs Disease market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Lou Gehrigs Disease in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Lou Gehrigs Disease manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        AB Science
        Avicena Group
        Biogen
        BrainStorm Therapeutics
        Covis Pharmaceutical Inc.
        Cytokinetics Inc.
        Eisai Co. Ltd.
        GlaxoSmithKline plc.
        Ionis Pharmaceuticals, Inc.
        Mitsubishi Tanabe Pharma Corp.
        Neuralstem Inc.
        Neuraltus Pharmaceuticals Inc.
        Newron Pharmaceuticals S.p.A.
        Nutra Pharma Corp.
        Pharnext SAS
        Q-Therapeutics Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Riluzole
        Edaravone (Radicava)

        Segment by Application
        Hospital Pharmacies
        Retail & Online Pharmacie

        Buy now